Secondary Logo

Journal Logo

Articles by Michael H. Goldstein, M.D.

A Phase 2 Exploratory Study of a Novel Interleukin-1 Receptor Inhibitor (EBI-005) in the Treatment of Moderate-to-Severe Allergic Conjunctivitis

Goldstein, Michael H.; Tubridy, Karen L.; Agahigian, Jennifer; More

Eye & Contact Lens. 41(3):145-155, May 2015.